Patents by Inventor Bartholomeus C.J.M. Fauser

Bartholomeus C.J.M. Fauser has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Progesterone Antagonist and Selective Progesterone Modulator in the Treatment of Excessive Uterine Bleeding
    Publication number: 20150051180
    Abstract: Progesterone antagonists and SPRM are useful to prepare a medication for the treatment or the prophylaxis of excessive uterine bleeding in women with spontaneous or iatrogenic coagulation disorders such as thrombopenia, coagulation factor deficiency or anti-coagulant therapy. Treatment will last from 1 day to 180 days.
    Type: Application
    Filed: October 7, 2013
    Publication date: February 19, 2015
    Applicant: PregLem S.A.
    Inventors: Bartholomeus C.J.M. Fauser, Ernest Loumaye
  • Progesterone Antagonist and Selective Progesterone Modulator in the Treatment of Excessive Uterine Bleeding
    Publication number: 20140100208
    Abstract: Progesterone antagonists and SPRM are useful to prepare a medication for the treatment or the prophylaxis of excessive uterine bleeding in women with spontaneous or iatrogenic coagulation disorders such as thrombopenia, coagulation factor deficiency or anti-coagulant therapy. Treatment will last from 1 day to 180 days.
    Type: Application
    Filed: October 7, 2013
    Publication date: April 10, 2014
    Applicant: PregLem S.A.
    Inventors: Bartholomeus C.J.M. Fauser, Ernest Loumaye
  • Progesterone antagonist and selective progesterone modulator in the treatment of excessive uterine bleeding
    Patent number: 8569274
    Abstract: Progesterone antagonists and SPRM are useful to prepare a medication for the treatment or the prophylaxis of excessive uterine bleeding in women with spontaneous or iatrogenic coagulation disorders such as thrombopenia, coagulation factor deficiency or anti-coagulant therapy. Treatment will last from 1 day to 180 days.
    Type: Grant
    Filed: April 18, 2008
    Date of Patent: October 29, 2013
    Assignee: Preglem S.A.
    Inventors: Bartholomeus C. J. M. Fauser, Ernest Loumaye
  • Progesterone Antagonist and Selective Progesterone Modulator in the Treatment of Excessive Uterine Bleeding
    Publication number: 20100190758
    Abstract: Progesterone antagonists and SPRM are useful to prepare a medication for the treatment or the prophylaxis of excessive uterine bleeding in women with spontaneous or iatrogenic coagulation disorders such as thrombopenia, coagulation factor deficiency or anti-coagulant therapy. Treatment will last from 1 day to 180 days.
    Type: Application
    Filed: April 18, 2008
    Publication date: July 29, 2010
    Applicant: PreLem S.A.
    Inventors: Bartholomeus C.J.M. Fauser, Ernest Loumaye